Royalty Pharma (RPRX)
undefined
undefined%
At close: undefined
25.84
0.02%
After-hours Jan 03, 2025, 04:00 PM EST

Royalty Pharma Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for RPRX stock have an median target of 41, with a low estimate of 28 and a high estimate of 51. The median target predicts an increase of 58.67% from the current stock price of 25.84.

Analyst Consensus: Buy
Target Low Average Median High
Price $28 $41.67 $41 $51
Change 8.36% 61.26% 58.67% 97.37%

AI Analyst Report

According to 6 stock analyst, the rating for Royalty Pharma is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Feb 24Apr 24Jun 24Jul 24Aug 24Oct 24
Strong Buy 000010
Buy 210101
Hold 001000
Sell 000000
Strong Sell 000000
Total 2 1 1 1 1 1

Financial Forecast this Year

Revenue This Year
2.84B
from -
Increased by ∞B%
Revenue Next Year
3.06B
from 2.84B
Increased by 7.7%
EPS This Year
2.04
from null
Increased by ∞B%
EPS Next Year
2.14
from 2.04
Increased by 4.9%